Prevalence of lymphoreticular prion protein accumulation in UK tissue samples

This study aims to provide an estimate of the number of individuals in the UK who may be incubating variant Creutzfeldt‐Jakob disease and at risk of causing iatrogenic spread of the disease. Lymphoreticular accumulation of prion protein is a consistent feature of variant Creutzfeldt‐Jakob at autopsy and has also been demonstrated in the pre‐clinical phase. Immunohistochemical accumulation of prion protein in the lymphoreticular system remains the only technique that has been shown to predict neurological disease reliably in animal prion disorders. In this study, immunohistochemistry was used to demonstrate the presence of prion protein, with monoclonal antibodies KG9 and 3F4, in surgically removed tonsillectomy and appendicectomy specimens. The samples were collected from histopathology departments across the UK and anonymised prior to testing. Samples were tested from 16 703 patients (14 964 appendectomies, 1739 tonsillectomies), approximately 60% of whom were from the age group 20–29 years at operation. Twenty‐five per cent of the samples were excluded from the final analyses because they contained inadequate amounts of lymphoid tissue. Three appendicectomy samples showed lymphoreticular accumulation of prion protein, giving an estimated prevalence of 3/12 674 or 237 per million (95% CI 49–692 per million). The pattern of lymphoreticular accumulation in two of these samples was dissimilar from that seen in known cases of variant Creutzfeldt‐Jakob disease. Although it is uncertain whether immunohistochemical accumulation of prion protein in the lymphoreticular system is specific for variant Creutzfeldt‐Jakob disease, it has not been described in any other disease, including other forms of human prion disease or a range of inflammatory and infective conditions. These findings reinforce the importance of measures taken by the UK Department of Health to reduce the risk of spread of variant Creutzfeldt‐Jakob via blood products and surgical instruments, and of the urgency to proceed with large‐scale screening of fresh tonsil specimens for the presence of prion protein. Copyright © 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  D. Taylor,et al.  Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie , 2005, Archives of Virology.

[2]  C. Wiley,et al.  Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt–Jakob disease , 2004, Journal of Clinical Pathology.

[3]  J Mackenzie,et al.  Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion , 2004, The Lancet.

[4]  A. Aguzzi,et al.  Creutzfeldt–Jakob disease and inclusion body myositis: Abundant disease‐associated prion protein in muscle , 2004, Annals of neurology.

[5]  J. Ironside,et al.  Variant Creutzfeldt-Jakob disease. , 2004, Folia neuropathologica.

[6]  W. Nailon,et al.  Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. , 2004, The American journal of pathology.

[7]  I-han Chou.  Strain of unknown prions weighs heavily on Japan, Italy , 2003, Nature Medicine.

[8]  A. Aguzzi,et al.  Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. , 2003, The New England journal of medicine.

[9]  S. Laboissiere,et al.  A prion protein epitope selective for the pathologically misfolded conformation , 2003, Nature Medicine.

[10]  A. Ghani,et al.  Updated projections of future vCJD deaths in the UK , 2003 .

[11]  J. Collinge,et al.  BSE prions propagate as either variant CJD‐like or sporadic CJD‐like prion strains in transgenic mice expressing human prion protein , 2002, The EMBO journal.

[12]  N. Hunter,et al.  Transmission of prion diseases by blood transfusion. , 2002, The Journal of general virology.

[13]  A. Ghani,et al.  Accumulation of prion protein in tonsil and appendix: review of tissue samples , 2002, BMJ : British Medical Journal.

[14]  C. V. van Duijn,et al.  Sporadic Creutzfeldt–Jakob disease and surgery: A case–control study using community controls , 2002, Neurology.

[15]  S. Hall,et al.  Selective expression of prion protein in peripheral tissues of the adult mouse , 2002, Neuroscience.

[16]  S. Prusiner,et al.  Prions in skeletal muscle , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Neal,et al.  Possible underascertainment of variant Creutzfeldt-Jakob disease: a systematic study , 2002, Journal of neurology, neurosurgery, and psychiatry.

[18]  A. Ghani,et al.  Estimating the human health risk from possible BSE infection of the British sheep flock , 2002, Nature.

[19]  J. Ironside,et al.  Pathological diagnosis of variant Creutzfeldt‐Jakob disease , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[20]  A. Valleron,et al.  Estimation of Epidemic Size and Incubation Time Based on Age Characteristics of vCJD in the United Kingdom , 2001, Science.

[21]  G. J. Raymond,et al.  Long-Term Subclinical Carrier State Precedes Scrapie Replication and Adaptation in a Resistant Species: Analogies to Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease in Humans , 2001, Journal of Virology.

[22]  S. Cousens,et al.  Predictability of the UK Variant Creutzfeldt-Jakob Disease Epidemic , 2001, Science.

[23]  J. Ironside,et al.  Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues , 2001, The Lancet.

[24]  J. Collinge,et al.  Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay , 2001, The Lancet.

[25]  S. Brown,et al.  Jugular venous emboli of brain tissue induced in sheep by the use of captive bolt guns , 2001, Veterinary Record.

[26]  E. Fisher,et al.  Identification of multiple quantitative trait loci linked to prion disease incubation period in mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Hilton.  vCJD – predicting the future? , 2000, Neuropathology and applied neurobiology.

[28]  J. Miller,et al.  Preclinical Diagnosis of Scrapie by Immunohistochemistry of Third Eyelid Lymphoid Tissue , 2000, Journal of Clinical Microbiology.

[29]  Christl A. Donnelly,et al.  Predicted vCJD mortality in Great Britain , 2000, Nature.

[30]  A. Ghani,et al.  Retrospective study of prion-protein accumulation in tonsil and appendix tissues , 2000, The Lancet.

[31]  M. Coleman,et al.  Extent of misclassification of death from Creutzfeldt-Jakob disease in England 1979-96: retrospective examination of clinical records , 2000, BMJ : British Medical Journal.

[32]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[33]  C. Masters,et al.  Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study , 1999, The Lancet.

[34]  J Collinge,et al.  Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples , 1999, The Lancet.

[35]  R. Bradley.  BSE transmission studies with particular reference to blood. , 1999, Developments in biological standardization.

[36]  J. Zajicek,et al.  Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease , 1998, The Lancet.

[37]  S. Pileri,et al.  The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. , 1998, Journal of clinical pathology.

[38]  M. Smits,et al.  Tonsillar biopsy and PrPSc detection in the preclinical diagnosis of scrapie , 1998, Veterinary Record.

[39]  R. Riek,et al.  Prion (PrPSc)-specific epitope defined by a monoclonal antibody , 1997, Nature.

[40]  S. Cousens,et al.  Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent , 1997, Nature.

[41]  Andrew F. Hill,et al.  The same prion strain causes vCJD and BSE , 1997, Nature.

[42]  C. Donnelly,et al.  Transmission dynamics and epidemiology of BSE in British cattle , 1997, Nature.

[43]  R. G. Will,et al.  Predicting the CJD epidemic in humans , 1997, Nature.

[44]  Andrew F. Hill,et al.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.

[45]  M. Smits,et al.  Preclinical test for prion diseases , 1996, Nature.

[46]  A. Hofman,et al.  A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.

[47]  P. Brown,et al.  Human spongiform encephalopathy: The national institutes of health series of 300 cases of experimentally transmitted disease , 1994, Annals of neurology.

[48]  T. Kitamoto,et al.  Accumulation of abnormal prion protein in mice infected with Creutzfeldt-Jakob disease via intraperitoneal route: a sequential study. , 1993, The American journal of pathology.

[49]  P. Brown,et al.  "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease , 1992, The Lancet.

[50]  R. Kimberlin,et al.  Pathogenesis of scrapie in mice after intragastric infection. , 1989, Virus research.

[51]  C. Eklund,et al.  Pathogenesis of scrapie virus infection in the mouse. , 1967, The Journal of infectious diseases.